Standout Papers
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma (2015)
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer (2011)
- MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer (2017)
- Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors (2020)
- Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update (2022)
Immediate Impact
28 by Nobel laureates 9 from Science/Nature 97 standout
Citing Papers
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Cutaneous melanoma
2023 Standout
Works of Debra A. Patt being referenced
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Debra A. Patt | 4447 | 1719 | 711 | 1267 | 121 | 6.0k | |
| Julia A. Beaver | 2572 | 1414 | 404 | 1014 | 129 | 4.5k | |
| George Pentheroudakis | 4318 | 1429 | 587 | 1292 | 224 | 7.3k | |
| Laura F. Hutchins | 3952 | 1673 | 267 | 1448 | 120 | 7.1k | |
| Christophe Le Tourneau | 4735 | 2202 | 581 | 1578 | 320 | 8.4k | |
| Francisco Vera-Badillo | 3294 | 1600 | 398 | 1204 | 75 | 5.3k | |
| Aaron R. Hansen | 4019 | 2429 | 514 | 1449 | 326 | 7.4k | |
| David E. Gerber | 5231 | 4268 | 574 | 1105 | 284 | 9.2k | |
| Alan B. Sandler | 4405 | 3602 | 383 | 1026 | 107 | 7.4k | |
| Paul Ruff | 6251 | 2538 | 381 | 1225 | 153 | 8.6k | |
| David J. Liewehr | 3013 | 1678 | 539 | 1202 | 116 | 7.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...